2017 Executive Panel

Big Data in Healthcare: Another New New Thing or the Real Deal?


Robert S. Galvin, MD, MBA [Moderator]


Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms owned by private equity companies. The focus is on using purchasing power to create innovative ways to achieve higher value health care, through improved population health, clinical quality and delivery system reforms. Currently, EH encompasses over 30 companies with healthcare spending exceeding $1.5B annually.

Before joining Blackstone, Dr. Galvin was Executive Director of Health Services and Chief Medical Officer for General Electric (GE) for fifteen years, where he was in charge of the design, financial and clinical performance of GE’s health programs.  He was also responsible for health policy strategies affecting employees. Dr. Galvin is a nationally recognized leader in the areas of market-based health policy and financing, quality measurement and payment reform.His work has been widely published in the New England Journal of Medicine and Health Affairs and he was a co-founder of the Leapfrog Group and founder of two other groups, Bridges to Excellence and Catalyzing Payment Reform, all innovative non-profits that have helped drive the quality agenda.  

Dr. Galvin is a member of the Institute of Medicine and sits on the IOM’s Board on Health Care Services. He is also on the Board of Directors of the National Quality Forum and a member of the National Advisory Council for the Agency for Healthcare Research and Quality (AHRQ). Dr. Galvin is Professor Adjunct of Medicine and Health Policy at Yale. His work has received awards from the National Business Group on Health, the Healthcare Financial Management Association and the National Coalition for Cancer Survivorship. He is a fellow of the American College of Physicians.

Harlan Krumholz, MD


Harlan Krumholz is a cardiologist, health care scientist, and health care improvement expert at Yale University where he is the Harold H. Hines, Jr.Professor of Medicine and Co-Director of the Robert Wood Johnson Foundation Clinical Scholars Program. He is the Director of the Yale New Haven Health Center for Outcomes Research and Evaluation (CORE). He has led research and initiatives to improve the quality and outcomes of clinical decisions and health care delivery,reduce disparities, enable transparency in practice and research, and avoid wasteful practices. His team is guiding federal efforts to measure and promote health care value. Dr. Krumholz established the Yale Open Data Access Project to promote data sharing and open science. He founded the Yale CORE Big Data to Knowledge initiative, aimed to deliver novel methodological approaches and tools to generate meaningful knowledge from large, complex healthcare data collections. He is also a scientific director of many large scale population-based and clinical projects in China with the National Center for Cardiovascular Diseases, including the Million Persons Project, a precision medicine initiative that will complete enrollment of 5 million participants by 2020. Dr. Krumholz founded Hugo, a mobile app to empower people with their health-related data, promoting the possibility of a consumer-mediated information platform. He is a founding member of the Board of Governors of the Patient-Centered Outcomes Research Institute. Dr. Krumholz received a BS from Yale, an MD from Harvard Medical School, and a Masters in Health Policy and Management from the Harvard University School of Public Health.

Farzad Mostashari, MD, ScM



Dr. Farzad Mostashari is the CEO of Aledade, a start-up he co-founded aimed at helping primary care doctors transform their practices and form accountable care organizations (ACOs). Prior to Aledade, he was a Visiting Fellow at the Brookings Institution in Washington DC, where he focused on payment reform and delivery system transformation. He served from 2011-2013 as the National Coordinator for Health Information Technology where he coordinated US efforts to build a health information technology infrastructure for healthcare reform and consumer empowerment. During his tenure at the Office of the National Coordinator, including his two years as Principal Deputy, he led the implementation of the Health IT for Economic and Clinical Health (HITECH) Act. He also collaborated with the Centers for Medicare and Medicaid Services on the design and implementation of the “Meaningful Use” Incentive Program, in addition to programs for health information exchange, health IT workforce, research, and privacy and security. Previously, Dr. Mostashari served at the New York City Department of Health and Mental Hygiene as Assistant Commissioner for the Primary Care Information Project, where he co-led agile development of population health management functionality within a commercial EHR. Dr. Mostashari also led the NYC Center of Excellence in Public Health Informatics and an Agency for Healthcare Research and Quality-funded project focused on quality measurement at the point of care. 

He conducted graduate training at the Harvard School of Public Health and Yale Medical School, served his internal medicine residency at Massachusetts General Hospital, and completed the CDC’s Epidemic Intelligence Service program. He was a lead investigator in the outbreaks of West Nile Virus, and anthrax in New York City, and among the first developers of real-time nationwide electronic disease surveillance systems.

Kathy McGroddy Goetz, PhD


Kathy McGroddy Goetz is the Vice President of Global Partnerships & Alliances Management for IBM Watson Health. In this role, she is responsible for managing strategic collaborations with key industry leaders to address the world’s most pressing health challenges. In addition to her business and solution leadership, she manages the ongoing relationship with IBM Researchto foster continuing innovation for future offerings.

Dr. McGroddy Goetz has spent much of her 24-year career at IBM innovating at the intersection of advanced technologies and new business models, with an emphasis on Healthcare and Life Sciences solutions.She has led teams in research & development spanning hardware and software, as well as business development organizations focused on research commercialization, strategic partnerships, mergers &acquisitions. She spent two years as Director of Corporate Technology leading IBM’s technology strategy and has significant expertise developing innovative medical imaging solutions leveraging advanced processing, analytics and cloud computing.She has formed many deep collaborations and business partnerships around the world as an IBM executive and played a critical role in the corporation’s launch of Watson Health, called a “moon shot” by CEO Ginni Rometty.

Dr. McGroddy Goetz earned a B.S. in physics from SUNY Binghamton and a Ph.D. in molecular biophysics from Cornell University where she studied protein-ligand interactions using NMR spectroscopy and molecular dynamics simulations. She holds 4 patents and is a frequent speaker at industry and technology conferences.

Dr. McGroddy Goetz is also an avid runner and triathlete as well as a volunteer coach for adult running programs. She co-founded the New Fairfield Track Club in 2006 and served as President and Treasurer for two years each. She lives in Ridgefield, CT with her husband and children